StockData
Tvardi Therapeutics, Inc. logo

Tvardi Therapeutics, Inc. (TVRD) stock

TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.01−0.09 (-8.18%)

Close on Nov 17, 2026Market cap $13.47MP/E –Yield 0.00%

Tvardi Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2021 it was 100.0%.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2021Dec 31, 2021100.0%–

More Tvardi Therapeutics figures

See a number that looks wrong?